Onyx Healthcare, Inc.(TW:6569)
NT$79.60-0.80 (-1.00%)
TW:6569
Onyx Healthcare, Inc. financials statements
NT$79.60
At close:-0.80 (-1.00%)
Onyx Healthcare, Inc. (6569) Ratios
Onyx Healthcare, Inc. Ratios
TW:6569's free cash flow for Q2 2026 was NT$-51.67M. For the 2026 fiscal year, TW:6569's free cash flow was decreased by NT$-6.35M and operating cash flow was NT$-45.32M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.17 | 2.43 | 2.85 | 2.94 | 1.62 |
| Quick Ratio | 1.51 | 1.63 | 2.05 | 1.97 | 0.99 |
| Cash Ratio | 0.97 | 0.96 | 1.20 | 1.03 | 0.42 |
| Solvency Ratio | 0.23 | 0.36 | 0.53 | 0.41 | 0.23 |
| Operating Cash Flow Ratio | 0.43 | 0.37 | 1.15 | 0.51 | 0.04 |
| Short-Term Operating Cash Flow Coverage | 1.17 | 1.37 | 9.35 | 15.59 | 0.15 |
| Net Current Asset Value | NT$ 250.45M | NT$ 271.17M | NT$ 343.30M | NT$ 373.01M | NT$ 31.25M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.12 | 0.10 | 0.10 | 0.19 |
| Debt-to-Equity Ratio | 0.19 | 0.16 | 0.14 | 0.14 | 0.31 |
| Debt-to-Capital Ratio | 0.16 | 0.14 | 0.12 | 0.12 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.07 | 0.08 | 0.09 | 0.13 |
| Financial Leverage Ratio | 1.37 | 1.36 | 1.36 | 1.41 | 1.66 |
| Debt Service Coverage Ratio | 0.44 | 1.45 | 6.87 | 16.66 | 1.33 |
| Interest Coverage Ratio | 11.17 | 20.76 | 59.21 | 68.67 | 54.56 |
| Debt to Market Cap | 0.06 | 0.04 | 0.03 | 0.05 | 0.09 |
| Interest Debt Per Share | 7.67 | 6.62 | 5.49 | 5.23 | 9.27 |
| Net Debt to EBITDA | -1.10 | -0.45 | -0.48 | -0.51 | 0.78 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.05% | 36.76% | 37.25% | 29.51% | 30.27% |
| EBIT Margin | 3.98% | 11.57% | 20.68% | 15.35% | 11.88% |
| EBITDA Margin | 5.64% | 13.24% | 22.29% | 16.94% | 14.20% |
| Operating Profit Margin | 3.98% | 7.29% | 14.61% | 15.26% | 11.95% |
| Pretax Profit Margin | 9.28% | 16.63% | 20.43% | 15.12% | 11.66% |
| Net Profit Margin | 8.51% | 14.58% | 17.10% | 12.68% | 10.61% |
| Continuous Operations Profit Margin | 8.51% | 14.51% | 17.09% | 8.76% | 6.35% |
| Net Income Per EBT | 91.63% | 87.65% | 83.69% | 83.86% | 91.04% |
| EBT Per EBIT | 233.34% | 228.11% | 139.83% | 99.10% | 97.54% |
| Return on Assets (ROA) | 5.19% | 8.59% | 12.46% | 10.32% | 7.49% |
| Return on Equity (ROE) | 7.11% | 11.71% | 16.89% | 14.58% | 12.43% |
| Return on Capital Employed (ROCE) | 2.95% | 5.12% | 12.51% | 14.82% | 11.31% |
| Return on Invested Capital (ROIC) | 2.50% | 4.24% | 10.23% | 12.32% | 9.29% |
| Return on Tangible Assets | 5.19% | 8.60% | 12.48% | 10.35% | 7.51% |
| Earnings Yield | 2.63% | 3.07% | 4.48% | 6.38% | 4.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.50 | 6.43 | 7.66 | 5.94 | 5.72 |
| Payables Turnover | 10.06 | 12.51 | 13.66 | 10.61 | 6.73 |
| Inventory Turnover | 3.47 | 2.90 | 3.81 | 3.62 | 3.09 |
| Fixed Asset Turnover | 3.46 | 3.29 | 3.89 | 4.81 | 17.42 |
| Asset Turnover | 0.61 | 0.59 | 0.73 | 0.81 | 0.71 |
| Working Capital Turnover Ratio | 2.81 | 2.36 | 2.52 | 3.61 | 3.20 |
| Cash Conversion Cycle | 117.65 | 153.51 | 116.69 | 127.85 | 127.70 |
| Days of Sales Outstanding | 48.67 | 56.74 | 47.67 | 61.46 | 63.81 |
| Days of Inventory Outstanding | 105.25 | 125.95 | 95.73 | 100.81 | 118.13 |
| Days of Payables Outstanding | 36.27 | 29.18 | 26.71 | 34.42 | 54.24 |
| Operating Cycle | 153.92 | 182.69 | 143.40 | 162.27 | 181.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.23 | 3.23 | 9.14 | 4.33 | 0.50 |
| Free Cash Flow Per Share | 3.86 | 3.04 | 7.37 | 3.92 | -8.12 |
| Dividend Paid and CapEx Coverage Ratio | 0.97 | 0.71 | 1.50 | 1.09 | 0.04 |
| Capital Expenditure Coverage Ratio | 11.49 | 17.58 | 5.16 | 10.75 | 0.06 |
| Operating Cash Flow Coverage Ratio | 0.56 | 0.50 | 1.70 | 0.84 | 0.05 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.10 | 0.23 | 0.10 | 0.01 |
| Free Cash Flow Yield | 3.53% | 1.99% | 4.96% | 4.61% | -9.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 38.02 | 32.62 | 22.33 | 15.66 | 24.43 |
| Price-to-Sales (P/S) Ratio | 3.23 | 4.75 | 3.82 | 1.99 | 2.56 |
| Price-to-Book (P/B) Ratio | 2.70 | 3.82 | 3.77 | 2.29 | 3.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 28.34 | 50.25 | 20.18 | 21.68 | -11.04 |
| Price-to-Operating Cash Flow Ratio | 25.87 | 47.39 | 16.26 | 19.66 | 179.75 |
| Price-to-Earnings Growth (PEG) Ratio | -0.99 | -1.10 | 0.99 | 0.33 | -1.08 |
| Enterprise Value Multiple | 56.25 | 35.45 | 16.65 | 11.23 | 18.81 |
| Enterprise Value | 4.17B | 5.83B | 5.54B | 3.04B | 3.21B |
| EV to EBITDA | 56.25 | 35.45 | 16.65 | 11.23 | 18.81 |
| EV to Sales | 3.17 | 4.70 | 3.71 | 1.90 | 2.67 |
| EV to Free Cash Flow | 27.79 | 49.63 | 19.61 | 20.74 | -11.52 |
| EV to Operating Cash Flow | 25.37 | 46.80 | 15.81 | 18.81 | 187.49 |
| Tangible Book Value Per Share | 40.47 | 40.22 | 39.58 | 37.31 | 30.00 |
| Shareholders’ Equity Per Share | 40.48 | 40.05 | 39.44 | 37.22 | 29.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | 0.13 | 0.16 | 0.16 | 0.10 |
| Revenue Per Share | 33.86 | 32.18 | 38.95 | 42.79 | 35.00 |
| Net Income Per Share | 2.88 | 4.69 | 6.66 | 5.43 | 3.72 |
| Tax Burden | 0.92 | 0.88 | 0.84 | 0.84 | 0.91 |
| Interest Burden | 2.33 | 1.44 | 0.99 | 0.99 | 0.98 |
| Research & Development to Revenue | 0.09 | 0.10 | 0.05 | 0.05 | 0.07 |
| SG&A to Revenue | 0.21 | 0.20 | 0.17 | 0.15 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Income Quality | 1.46 | 0.60 | 1.37 | 0.67 | 0.12 |
Currency in TWD
